Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)

SHE:300026 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 5, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,566	11,386	12,738	17,064	23,523	13,759
Market Cap Growth	-8.44%	-10.61%	-25.35%	-27.46%	70.96%	30.42%
Enterprise Value	11,224	11,349	13,109	18,344	24,054	14,108
Last Close Price	3.85	3.79	4.21	5.60	7.67	4.45
PE Ratio	488.51	530.38	25.14	27.34	34.22	24.00
Forward PE	20.26	16.83	16.83	16.83	16.83	16.83
PS Ratio	2.02	1.97	2.09	2.57	3.07	2.12
PB Ratio	1.31	1.29	1.44	2.02	2.96	1.86
P/TBV Ratio	1.49	1.48	1.66	2.36	3.49	2.23
P/FCF Ratio	18.37	17.27	10.77	-	-	-
P/OCF Ratio	14.13	13.36	8.32	22.89	60.07	69.96
PEG Ratio	-	0.94	0.94	0.94	0.94	0.94
EV/Sales Ratio	1.96	1.96	2.15	2.76	3.14	2.17
EV/EBITDA Ratio	26.36	29.32	16.23	18.83	19.77	15.27
EV/EBIT Ratio	121.29	110.81	25.43	25.32	24.00	19.22
EV/FCF Ratio	17.83	17.22	11.08	-	-	-
Debt / Equity Ratio	0.08	0.10	0.17	0.25	0.25	0.16
Debt / EBITDA Ratio	1.62	1.95	1.78	2.03	1.55	1.25
Debt / FCF Ratio	1.09	1.29	1.30	-	-	-
Asset Turnover	0.50	0.50	0.50	0.55	0.70	0.70
Inventory Turnover	1.53	1.51	1.35	1.61	2.40	2.48
Quick Ratio	2.71	2.57	2.89	1.79	2.46	1.72
Current Ratio	4.03	3.79	4.29	2.76	3.31	2.44
Return on Equity (ROE)	0.34%	0.26%	5.79%	7.57%	8.74%	7.74%
Return on Assets (ROA)	0.50%	0.56%	2.63%	3.73%	5.75%	4.93%
Return on Capital (ROIC)	0.58%	0.64%	3.08%	4.42%	6.78%	5.74%
Return on Capital Employed (ROCE)	1.00%	1.10%	5.00%	7.30%	10.50%	9.40%
Earnings Yield	0.20%	0.19%	3.98%	3.66%	2.92%	4.17%
FCF Yield	5.44%	5.79%	9.29%	-0.15%	-1.21%	-2.67%
Dividend Yield	0.78%	0.79%	0.71%	0.53%	0.52%	0.90%
Payout Ratio	569.26%	638.70%	30.53%	30.56%	22.96%	31.73%
Buyback Yield / Dilution	26.93%	27.97%	-0.26%	0.53%	0.98%	-4.96%
Total Shareholder Return	27.69%	28.76%	0.46%	1.06%	1.50%	-4.06%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.